(IN BRIEF) ViiV Healthcare has secured European Commission approval for its long-acting HIV treatment, Vocabria + Rekambys, for adolescents aged 12 and older. This approval offers a significant advancement in HIV care, providing an injectable treatment option that reduces the … Read the full press release →
Posted in Business, European Union, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged adolescents, clinical trial, European Commission, GSK, Healthcare Innovation, HIV care, HIV treatment, HIV treatment options, long-acting injections, MOCHA study, partnership, Rekambys, ViiV Healthcare, Vocabria